We found two CpGs significantly associated with GA in START that were present in the TCF7L2 gene, whose risk alleles increase the risk of T2D by reducing insulin secretion and are also associated with a lower BMI [87, 88]. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.